Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of oral HTMC0435 tablets in advanced biliary tract cancer
CTR20230615Phase 2Active
- Sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HTMC0435 in biliary cancer, sponsored by Shanghai Huilun Pharmaceutical Co., Ltd.. Started Oct 2023; status: active.
02
Drugs
HTMC0435
03
Conditions
biliary cancer
Beyond the preview
Go deeper on CTR20230615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230615.